NCT04354727 2022-07-12A Study of APG-1252 in Patients With Myelofibrosis Who Progressed After Initial TherapyAscentage Pharma Group Inc.Phase 1/2 Withdrawn
NCT02805868 2016-10-24Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia MyelofibrosisNorthwestern UniversityPhase EARLY_PHASE1 Withdrawn